• 7994746216
  • esicon2017@gmail.com
  • All the abstracts submitted have been reviewed by the reviewers and acknowledgements have been mailed to the corresponding authors. If any of the authors have not received any response, please mail us at esicon2017science@gmail.com with title of your abstract in the subject line
  

Corporate Symposium

Corporate symposiums bring out cutting edge developments in molecules in use and those in research. The speakers in these symposium are key opinion leaders in endocrinology and diabetes. Join our national and international speakers for interesting sessions.

13/10/2017
HALL A

I CaRe for Diabetes (panel discussion with Experts)

Sponsor Boehringer Ingelheim
Speakers Dr. Arpan Dev Bhattacharya
Dr. Unnikrishnan AG
Dr. RV Jayakumar
HALL B

Sponsor AstraZeneca
Part 1
Topic
Lecture  (25 Mins ) / 5 Mins (Q/A)
What we Know and what’s likely to come
– SGLT2i Evolving landscape 
 – Dr AK Singh (Kolkata)
Part 2
Topic
Panel discussion  (30 mins)
Optimizing the use of SGLT2 Inhibitors
– A Clinical Perspective
Moderator Dr Krishna Seshadri (Chennai)
Panel 1 Dr Rajesh Rajput (Rohtak)
Panel 2 Dr Sujoy Ghosh ( Kolkata)
Panel 3 Dr Tiny Nair ( Trivandrum)
HALL C

Sponsor Novartis
Chair Person : Prof. Roy Taylor
Time Topic Speaker
2 Min Welcome and Introduction  
20 Min Connecting the Dots between
T2DM and NAFLD
Dr. Mala Dharmalingam
25 Min Reviewing Insulin resistance in
enhancing management of T2DM
Prof. Roy Taylor
10 Min Panel Discussion Faculty
14/10/2017
HALL A

Sponsor MSD
Time Topic Speaker
5:45 PM – 6:05 PM Reducing AIC in the Treatment of
Patients with Type 2 Diabetes:
-Why do we still care?
Dr. J.J. Mukherjee
6:10 PM – 6:30 PM Evolving patient care in Type 2
Patients with Type2 Diabetes:
The Role of Cardiovascular safety trials and
What they can tell us about Patient Care.
Dr. A.K. Singh
6:30 PM – 6:45 PM Clarifying the role for DPP-4 inhibitors
in the Treatment of atients with
Type 2 Diabetes at Risk of Heart Failure

Dr. Shashank Joshi
HALL B

Sponsor Lupin
Topic eG A1c Summit
Getting to the Heart of the Matter
HALL C

Sponsor Novo Nordisk
Time Topic Speaker
2 Min Welcome and Introduction ChairPerson
10 Min Utilizing innovation for Insulin Therapy
Co-formulation of basal & prandial insulin
Dr. Shashank Joshi,
Mumbai
20 Min Exploring the effect of GLP-1 Therapy Beyond glycemic benefits
-Cardiovascular & Renal Outcomes
Prof. Hans Devries
Amsterdam
15 Min CV outcome trials with insulins:
Learning from the DEVOTE results
Dr. Anil Bhansali,
Chandigarh
10 Min Panel Discussion Faculty